Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

By sjmartinez • July 24, 2024

Karpouzas GA, Ormseth SR, van Riel PLCM, Gonzalez-Gay MA, Corrales A, Rantapää-Dahlqvist S, Sfikakis PP, Dessein P, Tsang L, Hitchon C, El-Gabalawy H, Pascual-Ramos V, Contreras-Yáñez I, Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Semb AG, Misra DP, Hauge EM, Kitas G. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis. RMD Open. 2024 Jul 23;10(3):e004546. doi: 10.1136/rmdopen-2024-004546. PMID: 39043615.

Tags: Arthritis, biological therapy, cardiovascular diseases, Harbor UCLA, Inflammation, Publications, Rheumatoid, Rheumatology

Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections

Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade[...]

Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation

Rhee CM, Zisman-Ilani Y, Kalantar-Zadeh K, Nguyen DV. Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation. Curr Opin[...]

Sex hormones and sexual health in chronic kidney disease before and after kidney transplantation

Lobo AS, Vaughan L, Ainsworth AJ, Felt M, Elali I, Arriola-Montenegro J, Garovic VD, Kattah AG. Sex hormones and sexual health in chronic kidney disease[...]